{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:28:56Z","timestamp":1788866936095,"version":"build-2803163510"},"reference-count":28,"publisher":"The Endocrine Society","issue":"12","license":[{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Autonomously functioning thyroid nodules (AFTNs) constitute 5% to 7% of thyroid nodules and represent the second most common cause of hyperthyroidism following Graves\u2019 disease. Currently, radioactive iodine (RAI) and surgery are the standard treatment options, and both incur a risk of postprocedural hypothyroidism and other surgery and radiation-related complications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This work aimed at assessing the efficacy of radiofrequency ablation (RFA) as an alternative treatment option for resolving hyperthyroidism and the nodule volume rate reduction (VRR) and its associated adverse events.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 22 patients underwent RFA for a solitary AFTN. Seventy-two percent (n = 16) had subclinical hyperthyroidism, 9% (n = 2) had overt hyperthyroidism, and 18% (n = 4) were biochemically euthyroid on antithyroid medication. Average pretreatment TSH was 0.41 mIU\/L (SD = 0.98) and free T4 1.29\u2005ng\/dL (SD = 0.33). Following a single RFA session, hyperthyroidism resolved in 90.9% (n = 20) and average VRR (61.13%) was achieved within 3 to 6 months following the ablation. Except for 1 nodule, none of the nodules grew during the follow-up period (16.5 months). Two patients (9%) developed transient tachycardia requiring short-term beta-blocker therapy, and 2 developed mild hypothyroidism requiring levothyroxine therapy. Two patients developed recurrent hyperthyroidism and elected to undergo lobectomy and repeat RFA respectively. No serious adverse effects were noted in this cohort.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>RAI and\/or surgery represent the standard of care for toxic adenomas, but RFA shows excellent efficacy and safety profile. Therefore, at centers with RFA expertise, it should be considered an alternative treatment strategy, avoiding radiation and surgery-related complications.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jendso\/bvae175","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T13:38:55Z","timestamp":1729172335000},"source":"Crossref","is-referenced-by-count":5,"title":["Outcomes of Radiofrequency Ablation for Autonomously Functioning Thyroid Adenomas\u2014Mayo Clinic Experience"],"prefix":"10.1210","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8103-0815","authenticated-orcid":false,"given":"Maheswaran","family":"Dhanasekaran","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Schmitz","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Regina","family":"Castro","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aadil","family":"Rajwani","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Alan","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Hamadi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"John C","family":"Morris","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R","family":"Callstrom","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1408-8125","authenticated-orcid":false,"given":"Marius N","family":"Stan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,10,17]]},"reference":[{"issue":"12","key":"2025021210530827100_bvae175-B1","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/jamaoto.2015.1451","article-title":"Association of thyroid nodule size and Bethesda class with rate of malignant disease","volume":"141","author":"Magister","year":"2015","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"4","key":"2025021210530827100_bvae175-B2","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1089\/thy.2017.0547","article-title":"Monopolar radiofrequency ablation of thyroid nodules: a prospective Austrian single-center study","volume":"28","author":"Dobnig","year":"2018","journal-title":"Thyroid"},{"issue":"8","key":"2025021210530827100_bvae175-B3","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1007\/s00330-016-4690-y","article-title":"Complications encountered in ultrasonography-guided radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers","volume":"27","author":"Kim","year":"2017","journal-title":"Eur Radiol"},{"issue":"3","key":"2025021210530827100_bvae175-B4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.4158\/EP15905.OR","article-title":"Autonomously functioning thyroid nodules in patients &lt;21 years of age: the Rhode Island hospital experience from 2003-2013","volume":"22","author":"Hodax","year":"2016","journal-title":"Endocr Pract"},{"issue":"6","key":"2025021210530827100_bvae175-B5","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1515\/JPEM.2002.15.6.823","article-title":"Hot nodules in children and adolescents in western Poland from 1996 to 2000: clinical analysis of 31 patients","volume":"15","author":"Niedziela","year":"2002","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"8","key":"2025021210530827100_bvae175-B6","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archpediatrics.2010.114","article-title":"Diagnostic features of thyroid nodules in pediatrics","volume":"164","author":"Corrias","year":"2010","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2025021210530827100_bvae175-B7","first-page":"9","volume-title":"Toxic Adenoma and Toxic Multinodular Goiter","author":"Corvilain","year":"2000"},{"issue":"8","key":"2025021210530827100_bvae175-B8","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1210\/jc.2013-1796","article-title":"A standardized assessment of thyroid nodules in children confirms higher cancer prevalence than in adults","volume":"98","author":"Gupta","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2025021210530827100_bvae175-B9","doi-asserted-by":"crossref","first-page":"bvab110","DOI":"10.1210\/jendso\/bvab110","article-title":"Safety and efficacy of radiofrequency ablation of thyroid nodules-expanding treatment options in the United States","volume":"5","author":"Hussain","year":"2021","journal-title":"J Endocr Soc"},{"issue":"6","key":"2025021210530827100_bvae175-B10","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/thy.2010.0417","article-title":"Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists","volume":"21","author":"Bahn","year":"2011","journal-title":"Thyroid"},{"issue":"4","key":"2025021210530827100_bvae175-B11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s40477-015-0169-y","article-title":"Radiofrequency ablation for thyroid nodules: which indications? The first Italian opinion statement","volume":"18","author":"Garberoglio","year":"2015","journal-title":"J Ultrasound"},{"issue":"4","key":"2025021210530827100_bvae175-B12","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3348\/kjr.2018.19.4.632","article-title":"2017 Thyroid radiofrequency ablation guideline: Korean Society of Thyroid Radiology","volume":"19","author":"Kim","year":"2018","journal-title":"Korean J Radiol"},{"issue":"8","key":"2025021210530827100_bvae175-B13","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.mayocp.2017.12.011","article-title":"Outcomes of radiofrequency ablation therapy for large benign thyroid nodules: a mayo clinic case series","volume":"93","author":"Hamidi","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"2025021210530827100_bvae175-B14","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3174\/ajnr.A4276","article-title":"Treatment of benign thyroid nodules: comparison of surgery with radiofrequency ablation","volume":"36","author":"Che","year":"2015","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"2025021210530827100_bvae175-B15","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1089\/thy.2007.0274","article-title":"Radiofrequency ablation for an autonomously functioning thyroid nodule","volume":"18","author":"Baek","year":"2008","journal-title":"Thyroid"},{"issue":"1","key":"2025021210530827100_bvae175-B16","doi-asserted-by":"crossref","first-page":"E92","DOI":"10.1210\/jc.2012-2991","article-title":"Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer","volume":"98","author":"Papini","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025021210530827100_bvae175-B17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/CCO.0b013e32835a583d","article-title":"Radiofrequency and ethanol ablation for the treatment of recurrent thyroid cancers: current status and challenges","volume":"25","author":"Shin","year":"2013","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"2025021210530827100_bvae175-B18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1089\/thy.2014.0100","article-title":"Radiofrequency ablation for autonomously functioning thyroid nodules: a multicenter study","volume":"25","author":"Sung","year":"2015","journal-title":"Thyroid"},{"issue":"3","key":"2025021210530827100_bvae175-B19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/thy.2008.0202","article-title":"Thyroid nodules and related symptoms are stably controlled two years after radiofrequency thermal ablation","volume":"19","author":"Spiezia","year":"2009","journal-title":"Thyroid"},{"key":"2025021210530827100_bvae175-B20","unstructured":"Stan MN . Supplemenatary Material for \u201cOutcomes of Radiofrequency Ablation for Autonomously Functioning Thyroid Adenomas\u2014Mayo Clinic Experience\u201d. Methods descriptor [Dataset]. Dryad. 2024. Deposited October 28, 2024. 10.5061\/dryad.j9kd51cnt"},{"issue":"11","key":"2025021210530827100_bvae175-B21","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1210\/jcem.83.11.5257","article-title":"Treatment of large cold benign thyroid nodules not eligible for surgery with percutaneous ethanol injection","volume":"83","author":"Zingrillo","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025021210530827100_bvae175-B22","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1007\/s00330-008-0880-6","article-title":"Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients","volume":"18","author":"Jeong","year":"2008","journal-title":"Eur Radiol"},{"issue":"6","key":"2025021210530827100_bvae175-B23","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1148\/rg.220021","article-title":"Radiofrequency ablation of benign and malignant thyroid nodules","volume":"42","author":"Navin","year":"2022","journal-title":"Radiographics"},{"issue":"5","key":"2025021210530827100_bvae175-B24","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1089\/thy.2018.0604","article-title":"Image-Guided thyroid ablation: proposal for standardization of terminology and reporting criteria","volume":"29","author":"Mauri","year":"2019","journal-title":"Thyroid"},{"issue":"5","key":"2025021210530827100_bvae175-B25","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ultrasmedbio.2007.10.018","article-title":"US-guided percutaneous radiofrequency thermal ablation for the treatment of solid benign hyperfunctioning or compressive thyroid nodules","volume":"34","author":"Deandrea","year":"2008","journal-title":"Ultrasound Med Biol"},{"issue":"4","key":"2025021210530827100_bvae175-B26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.eprac.2022.02.011","article-title":"American association of clinical endocrinology disease state clinical review: the clinical utility of minimally invasive interventional procedures in the management of benign and malignant thyroid lesions","volume":"28","author":"Jasim","year":"2022","journal-title":"Endocr Pract"},{"issue":"4","key":"2025021210530827100_bvae175-B27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000508484","article-title":"2020 European thyroid association clinical practice guideline for the use of image-guided ablation in benign thyroid nodules","volume":"9","author":"Papini","year":"2020","journal-title":"Eur Thyroid J"},{"issue":"3","key":"2025021210530827100_bvae175-B28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/hed.26960","article-title":"Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease: an international multidisciplinary consensus statement of the American head and neck society endocrine surgery section with the Asia pacific society of thyroid surgery, associazione medici endocrinologi, British association of endocrine and thyroid surgeons, European thyroid association, Italian society of endocrine surgery units, Korean society of thyroid radiology, Latin American thyroid society, and thyroid nodules therapies association","volume":"44","author":"Orloff","year":"2022","journal-title":"Head Neck"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvae175\/59830157\/bvae175.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/8\/12\/bvae175\/60776365\/bvae175.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/8\/12\/bvae175\/60776365\/bvae175.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T10:54:12Z","timestamp":1739357652000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvae175\/7824723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,17]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,10,29]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvae175","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,10,17]]},"article-number":"bvae175"}}